| |
Original Artikel |
Journal |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
Drug Discoveries & Therapeutics |
2024―Feb―21 |
Evolving immune evasion and transmissibility of SARS-CoV-2: The emergence of JN.1 variant and its global impact |
Guanyong Ou, Yang Yang, Shengjie Zhang, Shiyu Niu, Qingxian Cai, Yingxia Liu, Hongzhou Lu |
| 2 |
[GO] |
Drug Discoveries & Therapeutics |
2023―Okt―29 |
Inhaled ciclesonide does not affect production of antibodies or elimination of virus in patients with COVID-19: Subanalysis of a multicenter, open-label randomized trial |
Manabu Suzuki, Akihiro Matsunaga, Tohru Miyoshi-Akiyama, Junko Terada-Hirashima, Kenji Sadamasu, Mami Nagashima, Jin Takasaki, Shinyu Izumi, Masayuki Hojo, Yukihito Ishizaka, Haruhito Sugiyama |
| 3 |
[GO] |
BioScience Trends |
2023―Jun―21 |
The priority for prevention and control of infectious diseases: Reform of the Centers for Disease Prevention and Control - Occasioned by "the WHO chief declares end to COVID-19 as a global health emergency" |
Mingyu Luo, Fuzhe Gong, Jinna Wang, Zhenyu Gong |
| 4 |
[GO] |
Drug Discoveries & Therapeutics |
2023―Jun―15 |
Autoimmune hepatitis following COVID-19 vaccination: Clinical characteristics of 35 reported cases |
Meirong Wang, Juan Qi, Yujuan Liu |
| 5 |
[GO] |
Intractable & Rare Diseases Research |
2023―Mai―23 |
Health-related quality of life (HRQoL) and psychological impact of the COVID-19 pandemic on patients with myasthenia gravis |
Irune García, Oscar Martínez, Juan Francisco López-Paz, Monika Salgueiro, Alicia Aurora Rodríguez, Janire Zorita, Maddalen García-Sanchoyerto, Imanol Amayra |
| 6 |
[GO] |
Drug Discoveries & Therapeutics |
2023―Apr―28 |
University students' living conditions during the COVID-19 pandemic and predictors of their subjective health views: A cross-sectional survey |
Kiyoshi Hotta, Yukihiro Mori, Makoto Aoike, Yukihiro Shigeno, Yuka Aoyama, Mamoru Tanaka, Hana Kozai, Hatsumi Kawamura, Masato Tsurudome, Morihiro Ito |
| 7 |
[GO] |
Drug Discoveries & Therapeutics |
2023―Mrz―21 |
Examination of the utility of the COVID-19 detection kit, TRC Ready<sup>®</sup> SARS-CoV-2 i for nasopharyngeal swabs |
Satoru Ishii, Moto Kimura, Tohru Miyoshi-Akiyama, Ataru Moriya, Masami Kurokawa, Erina Isaka, Junko Terada-Hirashima, Jin Takasaki, Shinyu Izumi, Masayuki Hojo, Haruhito Sugiyama |
| 8 |
[GO] |
BioScience Trends |
2023―Mrz―13 |
Sequelae of long COVID, known and unknown: A review of updated information |
Tetsuya Asakawa, Qingxian Cai, Jiayin Shen, Ying Zhang, Yongshuang Li, Peifen Chen, Wen Luo, Jiangguo Zhang, Jinfeng Zhou, Hui Zeng, Ruihui Weng, Feng Hu, Huiquan Feng, Jun Chen, Jie Huang, Xiaoyin Zhang, Yu Zhao, Liekui Fang, Rongqing Yang, Jia Huang, Fuxiang Wang, Yingxia Liu, Hongzhou Lu |
| 9 |
[GO] |
Drug Discoveries & Therapeutics |
2023―Feb―25 |
Age distribution and disease severity of COVID-19 patients continued to change in a time-dependent manner from May 2021 to April 2022 in the regional core hospital in Japan |
Futoshi Kawaura, Takuya Kishi, Tadashi Yamamoto, Shiki Nakayama, Taku Goto, Reimi Tsurusawa, Toshio Katagiri, Kohei Yamanouchi, Ayako Matsuo, Naomi Kobayashi-Watanabe, Tomohiro Imamura, Yoshitaka Hirooka, Kuniyasu Takagi, Tsukuru Umemura, Kazuma Fujimoto, Shinichiro Hayashi, Ayako Takamori |
| 10 |
[GO] |
Drug Discoveries & Therapeutics |
2023―Feb―24 |
A fast RT-qPCR system significantly shortens the time for SARS-CoV-2 nucleic acid test |
Hongjie Dong, Kundi Zhang, Junmei Zhang, Yumeng Xiao, Fengyu Zhang, Maofeng Wang, Hongwei Wang, Guihua Zhao, Shiling Xie, Xiaohong Xie, Wei Hu, Kun Yin, Lichuan Gu |
| 11 |
[GO] |
BioScience Trends |
2023―Feb―10 |
Simulation of SARS-CoV-2 epidemic trends in Tokyo considering vaccinations, virus mutations, government policies and PCR tests |
Jianing Chu, Hikaru Morikawa, Yu Chen |
| 12 |
[GO] |
Drug Discoveries & Therapeutics |
2023―Feb―01 |
Factors affecting health-related quality of life among firefighters during the COVID-19 pandemic: A single-center study |
Yukihiro Shigeno, Yukihiro Mori, Kiyoshi Hotta, Yuka Aoyama, Mamoru Tanaka, Hana Kozai, Makoto Aoike, Hatsumi Kawamura, Masato Tsurudome, Morihiro Ito |
| 13 |
[GO] |
BioScience Trends |
2023―Jan―21 |
Different clinical guidelines, common goal: To reduce COVID-19 mortality |
Liqin Sun, Jiaye Liu, Fang Zhao, Jun Chen, Hongzhou Lu |
| 14 |
[GO] |
BioScience Trends |
2023―Jan―16 |
Pre-enriched saline gargle samples for detection of SARS-CoV-2 |
Peng Xu, Jing Chen, Chengchen Qian, Wenqiang Yu |
| 15 |
[GO] |
BioScience Trends |
2023―Jan―15 |
For COVID-19, what are the priorities of normalized prevention and control strategies? |
Mingyu Luo, Fuzhe Gong, Jimin Sun, Zhenyu Gong |
| 16 |
[GO] |
BioScience Trends |
2023―Jan―01 |
Herbal medicines exhibit a high affinity for ACE2 in treating COVID-19 |
Bo Zhang, Fanghua Qi |
| 17 |
[GO] |
BioScience Trends |
2022―Dez―25 |
Trends in managing COVID-19 from an emerging infectious disease to a common respiratory infectious disease: What are the subsequent impacts on and new challenges for healthcare systems? |
Kenji Karako, Peipei Song, Yu Chen, Takashi Karako |
| 18 |
[GO] |
BioScience Trends |
2022―Dez―25 |
Is targeting angiotensin-converting enzyme 2 (ACE2) a prophylactic strategy against COVID-19? |
Jing Li, Yufen Yan, Fangzhou Dou, Jianjun Gao |
| 19 |
[GO] |
BioScience Trends |
2022―Dez―08 |
Can nasal irrigation with chlorine dioxide be considered as a potential alternative therapy for respiratory infectious diseases? The example of COVID-19 |
Jing Cao, Yirong Shi, Min Wen, Yuanyuan Peng, Qiqi Miao, Xiaoning Liu, Mingbin Zheng, Tetsuya Asakawa, Hongzhou Lu |
| 20 |
[GO] |
BioScience Trends |
2022―Dez―08 |
Focusing on development of novel sampling approaches and alternative therapies for COVID-19: Are they still useful in an era after the pandemic? |
Tetsuya Asakawa |
| 21 |
[GO] |
BioScience Trends |
2022―Dez―08 |
Verification of the efficiency of saline gargle sampling for detection of the Omicron variant of SARS-CoV-2, a pilot study |
Kun Qiao, Xiaoting Tao, Houming Liu, Mingbin Zheng, Tetsuya Asakawa, Hongzhou Lu |
| 22 |
[GO] |
Drug Discoveries & Therapeutics |
2022―Okt―25 |
Impact of inhaled ciclesonide on asymptomatic or mild COVID-19: A randomized trial |
Junko Terada-Hirashima, Manabu Suzuki, Yoshie Tsujimoto, Yoichiro Hamamoto, Yukari Uemura, Kenji Tsushima, Hideki Inoue, Shigeru Komatsu, Zenya Saito, Ryuta Tsuzuki, Masaki Okamoto, Yasuo To, Kyoji Moriya, Sadako Yoshizawa, Masahide Tanaka, Toshitaka Muto, Ayako Mikami, Jin Takasaki, Shinyu Izumi, Norio Ohmagari, Masayuki Hojo, Wataru Sugiura, Haruhito Sugiyama |
| 23 |
[GO] |
Drug Discoveries & Therapeutics |
2022―Okt―06 |
Cross-infection risks of SARS-CoV-2 while playing catch using a baseball: Creating a safe sporting environment during the COVID-19 pandemic |
Yoko Iio, Yukihiro Mori, Masato Tsurudome, Morihiro Ito |
| 24 |
[GO] |
BioScience Trends |
2022―Sep―11 |
An average of nearly 200,000 new infections per day over a six-week period: What is the impact of such a severe COVID-19 pandemic on the healthcare system in Japan? |
Kenji Karako, Peipei Song, Yu Chen, Takashi Karako |
| 25 |
[GO] |
Drug Discoveries & Therapeutics |
2022―Sep―05 |
Relaxation of all-case reporting of COVID-19 cases in Japan |
Kenji Karako |
| 26 |
[GO] |
Drug Discoveries & Therapeutics |
2022―Aug―20 |
Prevalence of SARS-CoV-2 antibodies among university athletic club members: A cross-sectional survey |
Yukihiro Mori, Mamoru Tanaka, Hana Kozai, Kiyoshi Hotta, Yuka Aoyama, Yukihiro Shigeno, Makoto Aoike, Hatsumi Kawamura, Masato Tsurudome, Morihiro Ito |
| 27 |
[GO] |
BioScience Trends |
2022―Jul―29 |
Heparin therapy in COVID-19: Call for randomized controlled trials (RCTs) |
Tingting Fang, Xianyang Pan, Ju Huang, Jun Chen, Shuli Song, Qilin Zhan |
| 28 |
[GO] |
BioScience Trends |
2022―Jul―16 |
The role of influenza in the era of COVID-19: Can we forget it? |
Ting Li, Tetsuya Asakawa, Hui Liu, Cordia Chu, Hongzhou Lu |
| 29 |
[GO] |
Drug Discoveries & Therapeutics |
2022―Jun―25 |
Evaluation of Japanese university students' perception of smoking, interest in quitting, and smoking behavior: An examination and public health challenges during the COVID-19 pandemic |
Makoto Aoike, Yukihiro Mori, Kiyoshi Hotta, Yukihiro Shigeno, Yuka Aoyama, Mamoru Tanaka, Hana Kouzai, Hatsumi Kawamura, Masato Tsurudome, Morihiro Ito |
| 30 |
[GO] |
Drug Discoveries & Therapeutics |
2022―Jun―24 |
Efficacy and safety of sotrovimab for vaccinated or unvaccinated patients with mild-to-moderate COVID-19 in the omicron era |
Takehiro Izumo, Nobuyasu Awano, Naoyuki Kuse, Keita Sakamoto, Kohei Takada, Yutaka Muto, Kazushi Fujimoto, Ayae Saiki, Yu Ito, Hiroaki Ota, Minoru Inomata |
| 31 |
[GO] |
BioScience Trends |
2022―Jun―21 |
How should designated COVID-19 hospitals in megacities implement a precise management strategy in response to Omicron? |
Jing Cao, Min Wen, Yirong Shi, Ting Huang, Yunlan Yi, Youfeng Su, Xiaohui Liu, Yanling Chao, Hongzhou Lu |
| 32 |
[GO] |
BioScience Trends |
2022―Jun―21 |
Treating patients infected with the SARS-CoV-2 Omicron variant with a traditional Chinese medicine, Shufeng Jiedu capsule |
Jing Zhang, Lili Liu, Guoliang Zhang, Mingqiang Li, Bitao Ma, Wenming Yang |
| 33 |
[GO] |
BioScience Trends |
2022―Jun―16 |
Needs of cancer patients during the SARS-CoV-2 Omicron lockdown: A population-based survey in Shanghai, China |
Minxing Chen, Ruijia Li, Gang Ding, Chunlin Jin |
| 34 |
[GO] |
Drug Discoveries & Therapeutics |
2022―Mai―05 |
Oral high-dose acetylcysteine: Effective against the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)? |
Guangbin Chen, Hongzhou Lu |
| 35 |
[GO] |
Drug Discoveries & Therapeutics |
2022―Apr―03 |
Antibody response of smokers to the COVID-19 vaccination: Evaluation based on cigarette dependence |
Yukihiro Mori, Mamoru Tanaka, Hana Kozai, Kiyoshi Hotta, Yuka Aoyama, Yukihiro Shigeno, Makoto Aoike, Hatsumi Kawamura, Masato Tsurudome, Morihiro Ito |
| 36 |
[GO] |
BioScience Trends |
2022―Mrz―16 |
An innovative two-wing model for balancing the demands of inpatients with COVID-19 and general medical service in a designated hospital for COVID-19 in Shenzhen, China |
Xiaoning Liu, Jing Cao, Yiling Ji, Ting Li, Zheng Zhu, Ting Huang, Hongzhou Lu |
| 37 |
[GO] |
Drug Discoveries & Therapeutics |
2022―Mrz―08 |
Effect of corticosteroids in patients with COVID-19 early stage pneumonia and risk of disease progression: An uncharted territory |
Anabel Franco-Moreno, María Soledad Acedo-Gutiérrez, Rodolfo Romero-Pareja, Juan Torres-Macho |
| 38 |
[GO] |
Drug Discoveries & Therapeutics |
2022―Mrz―08 |
Waning COVID-19 vaccine effectiveness in Japan |
Junko Kurita, Tamie Sugawara, Yasushi Ohkusa |
| 39 |
[GO] |
Drug Discoveries & Therapeutics |
2022―Mrz―08 |
The effects of curcumin as dietary supplement for patients with COVID-19: A systematic review of randomized clinical trials |
Basel Abdelazeem, Ahmed K. Awad, Merihan A. Elbadawy, Nouraldeen Manasrah, Bilal Malik, Amman Yousaf, Sarah Alqasem, Sandi Banour, Sarah Magdy Abdelmohsen |
| 40 |
[GO] |
Drug Discoveries & Therapeutics |
2022―Jan―14 |
Drug discovery to treat COVID-19 two years after its outbreak |
Jianjun Gao, Fusheng Sun |
| 41 |
[GO] |
Drug Discoveries & Therapeutics |
2022―Jan―14 |
Pneumothorax and pneumomediastinum in patients with COVID-19: A retrospective study from tertiary care institute in India |
Saurav Sekhar Paul, Bhavesh Mohan Lal, Animesh Ray, Ved Prakash Meena, Rohit Kumar Garg, Pawan Tiwari, Prashant Sirohiya, Saurabh Vig, Sushma Bhatnagar, Anant Mohan, Surabhi Vyas, Naveet Wig |
| 42 |
[GO] |
Drug Discoveries & Therapeutics |
2021―Dez―29 |
Potential therapeutic effect of Shufeng Jiedu capsule and its major herbs on coronavirus disease 2019 (COVID-19): A review |
Yayun Xu, Li Yang, Longfei Wang, Feihu Chen |
| 43 |
[GO] |
BioScience Trends |
2021―Dez―27 |
The strategy behind Japan's response to COVID-19 from 2020-2021 and future challenges posed by the uncertainty of the Omicron variant in 2022 |
Peipei Song, Takashi Karako |
| 44 |
[GO] |
BioScience Trends |
2021―Dez―17 |
From SARS to the Omicron variant of COVID-19: China's policy adjustments and changes to prevent and control infectious diseases |
Mingyu Luo, Qinmei Liu, Jinna Wang, Zhenyu Gong |
| 45 |
[GO] |
Drug Discoveries & Therapeutics |
2021―Okt―29 |
Post COVID-19 sequelae: A prospective observational study from Northern India |
Shivdas Naik, Soumendra Nath Haldar, Manish Soneja, Netto George Mundadan, Prerna Garg, Ankit Mittal, Devashish Desai, Praveen Kumar Trilangi, Sayan Chakraborty, Nazneen Nahar Begam, Bisakh Bhattacharya, Ganesh Maher, Niranjan Mahishi, Chaithra Rajanna, Swasthi S Kumar, Bharathi Arunan, J Kirtana, Ankesh Gupta, Diksha Patidar, Parul Kodan, Prayas Sethi, Animesh Ray, Pankaj Jorwal, Arvind Kumar, Neeraj Nischal, Sanjeev Sinha, Ashutosh Biswas, Naveet Wig |
| 46 |
[GO] |
Drug Discoveries & Therapeutics |
2021―Okt―27 |
Role of systemic corticosteroids in preventing hypoxia among patients with mild COVID-19: An observational study |
Anivita Aggarwal, Ankit Mittal, Manish Soneja, Sujay Halkur Shankar, Shivdas Naik, Parul Kodan, Neeraj Nischal, Pankaj Jorwal, Animesh Ray, Naveet Wig |
| 47 |
[GO] |
Drug Discoveries & Therapeutics |
2021―Okt―27 |
Antiviral effect of electrolyzed reduced water on SARS-CoV-2 |
Yoshinao Okajima, Masahiro Okajima, Mitsuo Ikeda, Yuko Wada, Ken-ichi Shimokawa, Fumiyoshi Ishii |
| 48 |
[GO] |
Drug Discoveries & Therapeutics |
2021―Okt―25 |
Does immunosuppressive property of non-steroidal anti-inflammatory drugs (NSAIDs) reduce COVID-19 vaccine-induced systemic side effects? |
Itsuro Kazama, Momono Senzaki |
| 49 |
[GO] |
BioScience Trends |
2021―Aug―29 |
Considerations and guidance to control the rebound in COVID-19 cases |
Qian Li, Xiangming Zhan, Jun Wang, Hongzhou Lu |
| 50 |
[GO] |
Drug Discoveries & Therapeutics |
2021―Aug―25 |
India and management of COVID-19: A case study on published guidelines |
Rohit Kumar, Ankit Mittal, Shreya Das Adhikari, Eram Afroz, Nitin Gupta |
| 51 |
[GO] |
BioScience Trends |
2021―Aug―24 |
Update: Drug treatment options for coronavirus disease 2019 (COVID-19) |
Yueming Shao, Jun Chen, Hongzhou Lu |
| 52 |
[GO] |
Drug Discoveries & Therapeutics |
2021―Jul―18 |
Emergency use of COVID-19 vaccines recommended by the World Health Organization (WHO) as of June 2021 |
Cui Xiaoni, Wang Pengxiang, Wei Zhun |
| 53 |
[GO] |
BioScience Trends |
2021―Jul―14 |
The impact of COVID-19 pandemic on the utilization of ambulatory care for patients with chronic neurological diseases in Japan: Evaluation of an administrative claims database |
Kenichiro Sato, Tatsuo Mano, Yoshiki Niimi, Atsushi Iwata, Tatsushi Toda, Takeshi Iwatsubo |
| 54 |
[GO] |
BioScience Trends |
2021―Jul―12 |
Infectious disease activity during the COVID-19 epidemic in Japan: Lessons learned from prevention and control measures |
Tatsuo Sawakami, Kenji Karako, Peipei Song, Wataru Sugiura, Norihiro Kokudo |
| 55 |
[GO] |
Drug Discoveries & Therapeutics |
2021―Jul―05 |
Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19 |
Qian Li, Jun Wang, Yang Tang, Hongzhou Lu |
| 56 |
[GO] |
Drug Discoveries & Therapeutics |
2021―Jul―05 |
Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India |
Neha Chopra, Mohit Chowdhury, Anupam K Singh, Khan MA, Arvind Kumar, Piyush Ranjan, Devashish Desai, Naveet Wig |
| 57 |
[GO] |
Drug Discoveries & Therapeutics |
2021―Jul―05 |
Antimicrobial resistance and COVID-19 syndemic: Impact on public health |
Ashima Jain Vidyarthi, Arghya Das, Rama Chaudhry |
| 58 |
[GO] |
BioScience Trends |
2021―Jun―30 |
Rapid evolution of the COVID-19 pandemic calls for a unified public health response |
Na He |
| 59 |
[GO] |
BioScience Trends |
2021―Jun―25 |
Impact of China's COVID-19 prevention and control efforts on outbreaks of influenza |
Qian Li, Jun Wang, Haiwei Lv, Hongzhou Lu |
| 60 |
[GO] |
BioScience Trends |
2021―Jun―15 |
Opportunities and challenges to the use of neutralizing monoclonal antibody therapies for COVID-19 |
Jie Su, Hongzhou Lu |
| 61 |
[GO] |
BioScience Trends |
2021―Jun―15 |
What is always necessary throughout efforts to prevent and control COVID-19 and other infectious diseases? A physical containment strategy and public mobilization and management |
Mingyu Luo, Jimin Sun, Zhenyu Gong, Zhen Wang |
| 62 |
[GO] |
BioScience Trends |
2021―Mrz―25 |
Rapid SARS-CoV-2 antigen detection potentiates early diagnosis of COVID-19 disease |
Ying Lv, Yuanyuan Ma, Yanhui Si, Xiaoyi Zhu, Lin Zhang, Haiyan Feng, Di Tian, Yixin Liao, Tiefu Liu, Hongzhou Lu, Yun Ling |
| 63 |
[GO] |
BioScience Trends |
2021―Mrz―25 |
Burnout in nurses during the COVID-19 pandemic in China: New challenges for public health |
Lin Zhang, Ling Chai, Yihong Zhao, Lin Wang, Wenxiu Sun, Lingqing Lu, Hongzhou Lu, Jianliang Zhang |
| 64 |
[GO] |
BioScience Trends |
2021―Mrz―18 |
COVID-19 vaccine research focusses on safety, efficacy, immunoinformatics, and vaccine production and delivery: a bibliometric analysis based on VOSviewer |
Yamin Chen, Luying Cheng, Rongna Lian, Ziwei Song, Jinhui Tian |
| 65 |
[GO] |
BioScience Trends |
2021―Mrz―18 |
New challenges to fighting COVID-19: Virus variants, potential vaccines, and development of antivirals |
Jun Chen, Hongzhou Lu |
| 66 |
[GO] |
Drug Discoveries & Therapeutics |
2021―Feb―27 |
Clinical profile and outcomes of asymptomatic vs. symptomatic travellers diagnosed with COVID-19: An observational study from a coastal town in South India |
Nitin Gupta, Anupa John, Mohammed Safeer Kokkottil, Muralidhar Varma, Shashikiran Umakanth, Kavitha Saravu |
| 67 |
[GO] |
BioScience Trends |
2021―Feb―22 |
Transitional care during COVID-19 pandemic in Japan: Calls for new strategies to integrate traditional approaches with information and communication technologies |
Yuka Sumikawa, Noriko Yamamoto-Mitani |
| 68 |
[GO] |
Drug Discoveries & Therapeutics |
2021―Feb―18 |
Multidrug treatment for COVID-19 |
Masashi Ohe, Ken Furuya, Houman Goudarzi |
| 69 |
[GO] |
BioScience Trends |
2021―Jan―28 |
Overview of the characteristics of and responses to the three waves of COVID-19 in Japan during 2020-2021 |
Kenji Karako, Peipei Song, Yu Chen, Wei Tang, Norihiro Kokudo |
| 70 |
[GO] |
Drug Discoveries & Therapeutics |
2020―Dez―30 |
Does coronaviruses induce neurodegenerative diseases? A systematic review on the neurotropism and neuroinvasion of SARS-CoV-2 |
Ines ElBini Dhouib |
| 71 |
[GO] |
Drug Discoveries & Therapeutics |
2020―Dez―29 |
COVID-19 in patients living with human immunodeficiency virus (HIV) infection: Challenges and way-forward |
Manasvini Bhatt, Manish Soneja, Nitin Gupta |
| 72 |
[GO] |
Drug Discoveries & Therapeutics |
2020―Dez―29 |
Approach to acute febrile illness during the COVID-19 pandemic |
Manasvini Bhatt, Manish Soneja, Nitin Gupta |
| 73 |
[GO] |
Drug Discoveries & Therapeutics |
2020―Dez―29 |
Analytical methods for the determination of remdesivir as a promising antiviral candidate drug for the COVID-19 pandemic |
Yaser Pashaei |
| 74 |
[GO] |
BioScience Trends |
2020―Dez―26 |
Tetracycline plus macrolide: A potential therapeutic regimen for COVID-19? |
Masashi Ohe, Ken Furuya, Houman Goudarzi |
| 75 |
[GO] |
BioScience Trends |
2020―Dez―24 |
Latest updates on COVID-19 vaccines |
Qian Li, Hongzhou Lu |
| 76 |
[GO] |
BioScience Trends |
2020―Dez―17 |
Efficacy of early hydroxychloroquine treatment in preventing COVID-19 pneumonia aggravation, the experience from Shanghai, China |
Yi Su, Yun Ling, Yuyan Ma, Lili Tao, Qing Miao, Qingfeng Shi, Jue Pan, Hongzhou Lu, Bijie Hu |
| 77 |
[GO] |
Drug Discoveries & Therapeutics |
2020―Okt―28 |
Is amiloride a promising cardiovascular medication to persist in the COVID-19 crisis? |
Mir S. Adil, S. Priya Narayanan, Payaningal R. Somanath |
| 78 |
[GO] |
BioScience Trends |
2020―Okt―24 |
An overview of potential therapeutic agents to treat COVID-19 |
Xueqin Dong, Zhenxue Tian, Chengwu Shen, Cuirong Zhao |
| 79 |
[GO] |
BioScience Trends |
2020―Okt―24 |
The development of a quarantine strategy is an important path to a normalized response to COVID-19 |
Han Zhu, Hongzhou Lu |
| 80 |
[GO] |
Drug Discoveries & Therapeutics |
2020―Sep―07 |
Association of ACE2 receptor and ACEIs/ARBs with disease severity in COVID-19 |
Shweta Sinha, Alka Sehgal, Rakesh Sehgal |
| 81 |
[GO] |
Drug Discoveries & Therapeutics |
2020―Sep―07 |
Laboratory diagnosis of COVID-19 in Africa: availability, challenges and implications |
Elijah Kolawole Oladipo, Ayodeji Folorunsho Ajayi, Aduragbemi Noah Odeyemi, Olawumi Elizabeth Akindiya, Emmanuel Tayo Adebayo, Ayomide Samuel Oguntomi, Moyosoluwa Precious Oyewole, Esther Moradeyo Jimah, Abayomi Adio Oladipo, Olumuyiwa Elijah Ariyo, Bukola Bisola Oladipo, Julius Kola Oloke |
| 82 |
[GO] |
Drug Discoveries & Therapeutics |
2020―Sep―07 |
Review of current clinical management guidelines for COVID-19 with special reference to India |
Rohit Kumar, Kutty Sharada Vinod, Ankit Mittal, Shreya Das Adhikari, Nitin Gupta |
| 83 |
[GO] |
Intractable & Rare Diseases Research |
2020―Sep―03 |
A case of coronavirus disease 2019 in acquired immunodeficiency syndrome patient: a case report and review of the literature |
Abdallah Qasim, Mohamed Mansour, Omar Kousa, Dana Awad, Bader Abuhazeem, Paul Millner, Manasa Velagapudi |
| 84 |
[GO] |
Drug Discoveries & Therapeutics |
2020―Jul―14 |
Re-tasking the use of pre-existing medications and potential therapeutic options for coronavirus disease (COVID-19): systematic review of clinical studies |
Bushra Hassan Marouf, Kawa Dizaye |
| 85 |
[GO] |
Drug Discoveries & Therapeutics |
2020―Jul―14 |
Traditional Chinese medicine to treat COVID-19: the importance of evidence-based research |
Jinjing Wang, Fanghua Qi |
| 86 |
[GO] |
Drug Discoveries & Therapeutics |
2020―Jun―24 |
Targeting lymphocyte Kv1.3-channels to suppress cytokine storm in severe COVID-19: Can it be a novel therapeutic strategy? |
Itsuro Kazama |
| 87 |
[GO] |
BioScience Trends |
2020―Jun―20 |
Exploration and correlation analysis of changes in Krebs von den Lungen-6 levels in COVID-19 patients with different types in China |
Mingshan Xue, Peiyan Zheng, Xiqing Bian, Zhifeng Huang, Huimin Huang, Yifeng Zeng, Haisheng Hu, Xiaoqing Liu, Luqian Zhou, Baoqing Sun, Jian-lin Wu, Nanshan Zhong |
| 88 |
[GO] |
Drug Discoveries & Therapeutics |
2020―Jun―15 |
Can mesenchymal stem cell therapy be the interim management of COVID-19? |
Chitra Bamba, Surinder P. Singh, Sangeeta Choudhury |
| 89 |
[GO] |
BioScience Trends |
2020―Jun―11 |
Potential for jaktinib hydrochloride to treat cytokine storms in patients with COVID-19 |
Xianmin Meng, Yun Ling, Li Zhang, Qian Zhang, Ping Dong, Tongyu Zhu, Hongzhou Lu |
| 90 |
[GO] |
BioScience Trends |
2020―Mai―27 |
Predicting intervention effect for COVID-19 in Japan: state space modeling approach |
Genya Kobayashi, Shonosuke Sugasawa, Hiromasa Tamae, Takayuki Ozu |
| 91 |
[GO] |
BioScience Trends |
2020―Mai―15 |
Does immune privilege result in recovered patients testing positive for COVID-19 again? |
Jufeng Xia |
| 92 |
[GO] |
BioScience Trends |
2020―Mai―08 |
Introduction on collective quarantine of close contacts of patients with COVID-19 for medical observation in China: from the perspective of frontline staff |
Chenjie Dong, Yuan Tian, Wenzhong Xu, Jiangjiang He, Duo Chen, Jie Zhu, Ping Lu |
| 93 |
[GO] |
Drug Discoveries & Therapeutics |
2020―Mai―05 |
Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far? |
Yuanyuan Zhang, Yanyan Zhong, Lin Pan, Jing Dong |
| 94 |
[GO] |
BioScience Trends |
2020―Apr―29 |
Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China |
Ying Zou, Hongying Guo, Yuyi Zhang, Zhengguo Zhang, Yu Liu, Jiefei Wang, Hongzhou Lu, Zhiping Qian |
| 95 |
[GO] |
BioScience Trends |
2020―Apr―26 |
Suggestions on surgical treatment during coronavirus disease 2019 (COVID-19) pandemic |
Zhiming Zhao, Mengyang Li, Rong Liu |
| 96 |
[GO] |
Drug Discoveries & Therapeutics |
2020―Apr―24 |
Treatment of SARS-CoV-2: How far have we reached? |
Waquar Ahsan, Shamama Javed, Mohammed Al Bratty, Hassan A. Alhazmi, Asim Najmi |
| 97 |
[GO] |
BioScience Trends |
2020―Apr―21 |
Asymptomatic carriers of COVID-19 as a concern for disease prevention and control: more testing, more follow-up |
Jiao Zhang, Shoucai Wu, Lingzhong Xu |
| 98 |
[GO] |
BioScience Trends |
2020―Apr―21 |
A practice of anesthesia scenario design for emergency cesarean section in patients with COVID-19 infection based on the role of standard patient |
Yin Kang, Longjiao Deng, Dengwen Zhang, Yuehong Wang, Gang Wang, Li Mei, Guobin Zhou, Haihua Shu |
| 99 |
[GO] |
Drug Discoveries & Therapeutics |
2020―Apr―20 |
Is GSK3β a molecular target of chloroquine treatment against COVID-19? |
Mohammed Noor Embi, Nagesswary Ganesan, Hasidah Mohd Sidek |
| 100 |
[GO] |
BioScience Trends |
2020―Apr―12 |
Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19) |
Jianjun Gao, Shasha Hu |
| 101 |
[GO] |
BioScience Trends |
2020―Apr―04 |
Macrolide treatment for COVID-19: Will this be the way forward? |
Masashi Ohe, Haruki Shida, Satoshi Jodo, Yoshihiro Kusunoki, Masahide Seki, Ken Furuya, Houman Goudarzi |
| 102 |
[GO] |
BioScience Trends |
2020―Mrz―31 |
Mobile field hospitals, an effective way of dealing with COVID-19 in China: sharing our experience |
Zhi Chen, Shan He, Fan Li, Junxiang Yin, Xiaoliang Chen |
| 103 |
[GO] |
Drug Discoveries & Therapeutics |
2020―Mrz―25 |
Facts and reflections on COVID-19 and anti-hypertensives drugs |
Gustavo H. Marin |
| 104 |
[GO] |
BioScience Trends |
2020―Mrz―18 |
Analysis of COVID-19 infection spread in Japan based on stochastic transition model |
Kenji Karako, Peipei Song, Yu Chen, Wei Tang |
| 105 |
[GO] |
Drug Discoveries & Therapeutics |
2020―Mrz―07 |
Discovering drugs to treat coronavirus disease 2019 (COVID-19) |
Liying Dong, Shasha Hu, Jianjun Gao |
| 106 |
[GO] |
BioScience Trends |
2020―Feb―24 |
COVID-19: Real-time dissemination of scientific information to fight a public health emergency of international concern |
Peipei Song, Takashi Karako |
| 107 |
[GO] |
BioScience Trends |
2020―Feb―18 |
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies |
Jianjun Gao, Zhenxue Tian, Xu Yang |
| 108 |
[GO] |
BioScience Trends |
2020―Feb―16 |
Challenges to the system of reserve medical supplies for public health emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China |
Xu Wang, Xiaoxi Zhang, Jiangjiang He |
| 109 |
[GO] |
BioScience Trends |
2020―Feb―08 |
Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment |
Zhenwei Wang, Xiaorong Chen, Yunfei Lu, Feifei Chen, Wei Zhang |
| 110 |
[GO] |
BioScience Trends |
2020―Jan―27 |
Drug treatment options for the 2019-new coronavirus (2019-nCoV) |
Hongzhou Lu |
